Investor Relations

May 09,2025

Summary of Consolidated Financial Results for the Year Ended March 31, 2025

May 09,2025

Notice Concerning Distribution of Dividends from Surplus

May 09,2025

Notice Concerning Revision of the Restricted Stock Compensation Plan

Mar. 28,2025

Notice Concerning Changes in Officers

Feb. 10,2025

Company overview

Feb. 4,2025

Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2025 (FY2024)

Feb. 4,2025

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2024

Nov. 12,2024

Financial Results for the First Half of the Fiscal Year Ending March 31, 2025 (FY2024)

Oct. 31,2024

Notice of Revision of Earnings Forecast

Oct. 31,2024

Notice of Partial Amendment to Dividend Policy and Revision (Increase) of Dividend Forecast

Oct. 31,2024

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2024

Aug. 08,2024

2024 Consolidated Financial Statements

Jul. 31,2024

Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 (FY2024)

Jul. 31, 2024

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2024

Jul. 03,2024

Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation

Jun.26,2024

Duties of Directors

Jun.26,2024

Notice of Resolutions of the 127 th Annual General Meeting of Shareholders

Jun.03,2024

Notice of the 127th Annual General Meeting of Shareholders

May 20,2024

Financial Results for the Fiscal Year Ended March 31, 2024

May 09,2024

Summary of Consolidated Financial Results for the Year Ended March 31, 2024

May 09,2024

Notice Concerning Distribution of Dividends from Surplus

Mar. 28,2024

Notice Concerning Changes in Officers

Jan. 31,2024

Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024

Jan. 31,2024

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2023